Core Insights - Colgate-Palmolive reported revenue of $4.91 billion for Q1 2025, a year-over-year decline of 3%, but exceeded Zacks Consensus Estimate by 1.15% [1] - The company's EPS for the quarter was $0.91, up from $0.86 a year ago, representing a surprise of 5.81% over the consensus estimate [1] Revenue Performance by Region - North America: Net sales of $998 million, slightly below the estimated $1 billion, with a year-over-year change of +0.1% [4] - Latin America: Net sales of $1.14 billion, exceeding the $1.09 billion estimate, but down 8.8% year-over-year [4] - Africa/Eurasia: Net sales of $271 million, slightly below the $273.66 million estimate, with a year-over-year decline of 1.8% [4] - Europe: Net sales of $690 million, above the $674.15 million estimate, reflecting a year-over-year decline of 3% [4] - Asia Pacific: Net sales of $690 million, below the $727.36 million estimate, with a year-over-year decline of 5.1% [4] - Pet Nutrition: Net sales of $1.12 billion, exceeding the $1.09 billion estimate, with a year-over-year increase of 1.5% [4] - Total Oral, Personal and Home Care: Net sales of $3.79 billion, slightly above the $3.77 billion estimate, with a year-over-year decline of 4.3% [4] Operating Profit Analysis - Total Oral, Personal and Home Care: Operating profit of $971 million, below the estimated $1.01 billion [4] - Corporate: Operating profit of -$153 million, better than the estimated -$182.49 million [4] - Pet Nutrition: Operating profit of $258 million, exceeding the $239.30 million estimate [4] Stock Performance - Colgate-Palmolive shares returned -0.5% over the past month, compared to the Zacks S&P 500 composite's -4.8% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]

Core Insights - Colgate-Palmolive surpassed earnings expectations in Q1 2025 despite a decline in overall sales, with GAAP revenue of $4.9 billion, down 3.1% from Q1 2024, but exceeding estimates by $45 million [1] Financial Performance - Non-GAAP EPS increased by 5.8% to $0.91, surpassing the estimate of $0.86 [2] - GAAP revenue decreased to $4.91 billion from $5.07 billion in Q1 2024, reflecting a 3.1% year-over-year decline [2] - Gross profit margin improved by 0.8 percentage points to 60.8% [2] - Operating profit margin increased by 1.2 percentage points to 21.9% [2][8] Business Overview - Colgate-Palmolive holds a 40.9% global market share in toothpaste and 31.9% in manual toothbrushes, with products marketed in over 200 countries [3] - The company emphasizes sustainability initiatives, including a commitment to recyclable toothpaste tubes [4] Geographic Performance - Europe saw a 5.4% organic sales increase due to balanced pricing and volume strategies [7] - Hill's Pet Nutrition achieved a 1.5% rise in net sales and a 2.9% boost in organic sales [7] - Latin America faced a 12.7% decline in net sales due to foreign exchange headwinds but managed a positive organic growth of 4% [7][6] Strategic Challenges - The company faces heightened global market competition, particularly from private labels, and ongoing raw material cost volatility [8] Future Outlook - Colgate-Palmolive projects low single-digit net sales growth for FY2025, with organic sales growth anticipated between 2% and 4% [9]

Core Viewpoint - Colgate-Palmolive reported quarterly earnings of $0.91 per share, exceeding the Zacks Consensus Estimate of $0.86 per share, marking a year-over-year increase from $0.86 per share [1] Financial Performance - The company achieved revenues of $4.91 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.15%, although this represents a decline from $5.07 billion in the same quarter last year [2] - Over the last four quarters, Colgate-Palmolive has exceeded consensus EPS estimates four times and topped revenue estimates three times [2] Stock Performance - Colgate-Palmolive shares have increased approximately 2% since the beginning of the year, contrasting with a decline of 6.8% in the S&P 500 [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.94, with projected revenues of $5.01 billion, and for the current fiscal year, the EPS estimate is $3.67 on revenues of $20.03 billion [7] - The trend of earnings estimate revisions is mixed, which could change following the recent earnings report [6] Industry Context - The Consumer Products - Staples industry is currently ranked in the top 37% of over 250 Zacks industries, suggesting that companies in the top half tend to outperform those in the bottom half by more than 2 to 1 [8]

智通财经APP获悉，鉴于特朗普政府发起的史无前例的关税战役，美国必需消费品领军者高露洁 (CL.US)的管理层预计今年全年可能将增加约2亿美元成本，并且高露洁下调了其销售额以及盈利数据未 来展望。 盘前交易中，高露洁股价小幅上行。今年截至周四收盘，该股累计上涨 2%，大幅跑赢今年跌超8%的美 股大盘——标普500指数。 无独有偶，美国日用品巨头保宝洁(PG.US)公布的最新业绩显示，在截至3月31日的季度中，2025财年第 三季度的销售额为198亿美元，同比下降 2.0%，不及市场预期;经调整后每股收益为1.54美元，高于分析 师普遍预计的1.53美元。该公司预计截至6月的财年每股收益为6.72至6.82美元，低于1月预期，但较上 年同期的6.59美元有所增长。 更重要的是，宝洁预计今年有机销售额同比增长约2%。这一与上年基本持平的增幅低于该公司1月份的 预测，当时该公司预计销售额将增长3%至5%。 宝洁CEO乔恩·莫勒在声明中表示："在充满挑战且动荡的消费市场和地缘政治环境下，本季度我们实现 了温和的有机销售额和每股收益增长。我们正在对近期前景进行适当调整，以反映潜在的市场状况。" 这家销售足迹遍及全球的牙 ...

Financial Performance - Net sales decreased by 3.1%, including a 4.4% negative impact from foreign exchange[21] - Organic sales increased by 1.4%, but experienced a 0.4% negative impact from lower private label pet volume[21] - GAAP and Base Business Gross profit margin increased 80 basis points to 60.8%[21] - Base Business EPS increased 6%[21] Strategic Investments - Advertising as a percentage of sales increased 30 basis points to 13.6% to support building brand health and strong innovation[21] Guidance - Net sales growth is now expected to be up low single digits, including a low-single-digit negative impact from foreign exchange[25] - Organic sales growth is now expected to be 2% to 4%, including the impact of the planned exit from private label pet nutrition over the course of 2025[27] - The company expects the incremental tariffs announced and in effect as of April 24, 2025 to have an incremental gross impact of approximately $200 million dollars to the cost of goods sold in 2025[30] Market Share - Global toothpaste market share was up 20 basis points on a volume basis[21] Company Overview - Colgate-Palmolive is a $20.1B global consumer products company with ~34,000 employees serving over 200 countries and territories[7]

Sales Performance - Approximately two-thirds of Colgate-Palmolive's net sales are generated from markets outside the U.S., with about 45% coming from emerging markets[90]. - Worldwide net sales were $4,911 million in Q1 2025, down 3.1% from Q1 2024, with organic sales increasing by 1.4%[112]. - Net sales in the Oral, Personal and Home Care segment were $3,792 million, down 4.3% from Q1 2024, while organic sales increased by 1.0%[113]. - Net sales in North America decreased 3.6% to $998 million, driven by volume declines of 2.3% and net selling price decreases of 0.7%[145]. - Net sales in Latin America decreased 8.7% to $1,143 million, impacted by negative foreign exchange of 12.7%[148]. - Net sales in Europe increased 2.5% to $690 million, with organic sales growth of 5.4% driven by the United Kingdom, Germany, and France[152]. - Net sales in Asia Pacific decreased 5.0% to $690 million, with organic sales declining 3.1% primarily due to the Greater China region[155]. - Net sales in the Hill's Pet Nutrition segment were $1,118 million, up 1.5% from Q1 2024, with organic sales increasing by 2.9%[115]. Profitability and Expenses - Gross profit decreased to $2,987 million in Q1 2025 from $3,039 million in Q1 2024, while gross profit margin increased to 60.8% from 60.0%[117][118]. - Selling, general and administrative expenses decreased by 1% to $1,898 million, with a percentage of net sales increasing to 38.6% from 37.8%[120][121]. - Operating profit increased by 3% to $1,076 million, with an operating profit margin of 21.9%, up 120 basis points from the previous year[126][127]. - Operating profit in North America decreased 8% to $196 million, with a margin of 19.6%, down 100 basis points from the previous year[147]. - Operating profit in Europe increased 12% to $172 million, with a margin of 24.9%, up 220 basis points[154]. - Operating profit for Hill's Pet Nutrition rose 30% to $258 million, with an operating profit margin of 23.1%, an increase of 510 basis points compared to the previous year[163]. Income and Earnings Per Share - Net income attributable to Colgate-Palmolive Company in Q1 2025 increased to $690 million, up from $683 million in Q1 2024, with diluted earnings per share rising to $0.85 from $0.83[141]. - Excluding certain charges, net income in Q1 2025 increased 4% to $743 million, and diluted earnings per share increased 6% to $0.91[142]. Costs and Charges - The company expects incremental gross costs of approximately $200 million in 2025 due to tariffs imposed by the United States and other countries[104]. - The company recorded a charge of $65 million related to a lawsuit under the Employee Retirement Income Security Act (ERISA) during the quarter ended March 31, 2025[101]. - Non-service related postretirement costs were $72 million in Q1 2025 compared to $22 million in Q1 2024[129]. - Colgate-Palmolive continues to experience higher raw and packaging material costs, which may adversely affect future results[107]. Strategic Initiatives - Colgate-Palmolive announced the acquisition of Care TopCo Pty Ltd, owner of the Prime100 pet food brand, which is expected to close in Q2 2025[93]. - The 2022 Global Productivity Initiative resulted in pretax costs of $36 million, aimed at reallocating resources towards strategic priorities and efficiencies[102]. - The company is focused on delivering consistent compounded earnings per share growth through organic sales growth and operational efficiencies[111]. - Colgate-Palmolive's business strategy includes prioritizing investments in high growth and high margin segments within Oral Care, Personal Care, and Pet Nutrition[99]. Market Conditions - The company faces heightened competitive activity in certain markets, impacting pricing pressures and relationships with key retailers[108]. - The global toothpaste market share was 40.9%, a decrease of 0.5 share points year-over-year, while the manual toothbrush market share increased to 31.9%, up 0.3 share points[114]. Cash Flow and Debt - Net cash provided by operations decreased by 12% to $600 million in Q1 2025, compared to $681 million in Q1 2024, mainly due to changes in working capital[173]. - Total debt increased to $8,269 million as of March 31, 2025, up from $7,949 million at the end of 2024[176]. Dividends and Capital Expenditures - The company announced an increase in the quarterly common stock dividend to $0.52 per share from $0.50, effective in Q2 2025[179]. - Capital expenditures for Q1 2025 were $124 million, with expectations for capital expenditures to be approximately 3.0% of net sales for the year[174]. IT and Internal Controls - The company is in the process of upgrading its enterprise IT system to SAP S/4 HANA, which is not expected to materially impact internal controls over financial reporting[189]. - As of March 31, 2025, the company's disclosure controls and procedures were evaluated and deemed effective by the management team[188]. - There were no material changes in the company's internal control over financial reporting during the most recent fiscal quarter[190]. - There is no material change in the information regarding market risk exposure as reported in the Annual Report for the year ended December 31, 2024[186].

Financial Performance - Net sales decreased by 3.1% to $4,911 million, while organic sales grew by 1.4%[3] - GAAP EPS increased by 2% to $0.85, and Base Business EPS rose by 6% to $0.91[3] - Gross profit margin improved by 80 basis points to 60.8%[3] - Total company operating profit increased by 3% to $1,076 million, with a margin of 21.9%[11] - Net income attributable to Colgate-Palmolive Company was $690 million in Q1 2025, compared to $683 million in Q1 2024[25] - Net income (GAAP) for 2025 was reported at $953 million, compared to $729 million in 2024[43] - Non-GAAP net income for 2025 was $1,018 million, an increase from $779 million in 2024[43] Sales and Market Share - Colgate maintained a global market share of 40.9% in toothpaste and 31.9% in manual toothbrushes year to date[3] - North America reported a 3.6% decline in net sales, while Latin America saw an 8.7% decrease[8] - Net sales for Q1 2025 were $4,911 million, a decrease of 3.1% compared to $5,065 million in Q1 2024[25] - North America net sales decreased by 3.6% in Q1 2025, while Europe saw an increase of 2.5%[36] Cash Flow and Debt - Net cash provided by operations was $600 million for the first three months of 2025[3] - Free cash flow before dividends was $476 million in Q1 2025, down from $555 million in Q1 2024[29] - Total debt rose to $8,269 million as of March 31, 2025, compared to $7,949 million at the end of 2024[27] Expenses and Profit Margins - Selling, general and administrative expenses (GAAP) for 2025 were $1,898 million, a decrease from $1,916 million in 2024[40] - Operating profit (GAAP) increased by 3% to $1,076 million in 2025 from $1,047 million in 2024[40] - Operating profit margin (GAAP) improved to 21.9% in 2025, up from 20.7% in 2024, reflecting a 120 basis point increase[40] - Selling, general and administrative expenses as a percentage of net sales (non-GAAP) was 38.3% in 2025, up from 37.8% in 2024[40] Tax and Working Capital - The effective tax rate improved to 23.7% in Q1 2025 from 24.6% in Q1 2024[25] - The effective tax rate for diluted earnings per share was 23.7% in 2025, slightly down from 24.6% in 2024[43] - The company reported a working capital as a percentage of sales of (3.3)% in Q1 2025, an improvement from (5.2)% in Q4 2024[27] Other Financial Metrics - Total assets increased to $16,647 million as of March 31, 2025, up from $16,046 million at the end of 2024[27] - Non-service related postretirement costs (GAAP) rose significantly to $72 million in 2025 from $22 million in 2024[40] - Other (income) expense, net (GAAP) decreased to $13 million in 2025 from $76 million in 2024[40] - Hill's division experienced a 1.5% increase in net sales, with a 30% rise in operating profit[11] Future Outlook - The company expects full-year 2025 net sales to increase by low single digits, with organic sales growth projected at 2% to 4%[6] - Advertising investment as a percentage of net sales increased by 30 basis points to 13.6%[5]

Market Overview - US stock index futures are all down, with Dow futures down 0.47%, S&P 500 futures down 0.31%, and Nasdaq futures down 0.26% [1] - European indices also show declines, with Germany's DAX down 0.07%, UK's FTSE 100 down 0.04%, France's CAC40 down 0.14%, and the Euro Stoxx 50 down 0.18% [2] - WTI crude oil increased by 1.25% to $63.05 per barrel, while Brent crude rose by 1.03% to $66.80 per barrel [2] US Stock Market Insights - Jefferies highlights a critical point for the S&P 500 index at 5500, which needs to be breached to recover from a 19% drop since February's historical high [3] - Christopher Wood from Jefferies suggests that the golden era for US stocks is over, predicting further declines in US equities, bonds, and the dollar [5] Automotive Industry - Japanese automakers saw a surge in US sales in March, with Toyota's sales up 8% to 231,336 units, Honda's up 13%, and Nissan's up 10% [4] Company Earnings Reports - Merck's Q1 earnings exceeded expectations with sales of $15.5 billion, although they anticipate a $200 million loss due to tariffs by 2025 [9] - American Airlines withdrew its 2025 profit guidance, reporting a Q1 net loss of $473 million, worsened by tariff pressures and government spending uncertainties [9] - Procter & Gamble lowered its annual organic sales growth forecast from 3%-5% to 2% due to tariff pressures and fluctuating consumer demand [10] - Sanofi's Q1 earnings surpassed expectations, driven by strong demand for its Dupixent drug, with sales of €9.89 billion [10] - IBM reported Q1 sales of $14.5 billion, exceeding expectations, but concerns remain regarding the impact of tariffs and government spending cuts on business [11] - Texas Instruments provided a positive Q2 earnings outlook, with expected revenue between $4.17 billion and $4.53 billion, driven by improved demand in industrial and automotive sectors [12] Technology Sector - Google Chrome's potential market value is estimated at over $50 billion, according to competitors, amid ongoing antitrust scrutiny [13] - TSMC plans to begin production using A14 chip technology in 2028, aiming to maintain its leadership in the semiconductor industry [13]

Core Viewpoint - Colgate-Palmolive Company (CL) is anticipated to report a decline in revenues for the first quarter of 2025, with expected revenues of $4.87 billion, reflecting a 3.8% decrease from the previous year [1] Revenue and Earnings Estimates - The consensus estimate for CL's earnings is 86 cents per share, expected to remain flat year over year, with a slight downward adjustment in the past week [2] - The model predicts a sales decline of 1.7% for the first quarter, with specific declines in various regions: 7.2% in Latin America, 1.5% in North America, 3% in Asia Pacific, and 4% in Africa/Eurasia, while Europe and Pet Nutrition are expected to see increases of 2.8% and 3% respectively [6] Market Challenges - CL's performance is likely impacted by inflationary pressures, foreign currency fluctuations, and weak performance in key regions, particularly in Latin America where currency devaluation has been significant [4] - In North America, the company faces challenges in maintaining pricing power due to increased promotional activity and competitive dynamics, which could further pressure profitability [5] Margin and Profitability - Persistent inflation in raw materials and packaging costs is squeezing margins, limiting the company's ability to reinvest in growth initiatives [7] - Despite these challenges, CL's gross margin is expected to expand by 130 basis points to 61.3% in the first quarter, supported by strong pricing and revenue growth management initiatives [10][9] Stock Performance and Valuation - CL shares have gained 7.8% over the past three months, outperforming the industry average growth of 2% [11] - The company trades at a forward 12-month P/E multiple of 25.16X, which is higher than the industry average of 20.89X and the S&P 500's average of 17.61X, indicating a relatively pricey valuation [14]

Core Viewpoint - Analysts project that Colgate-Palmolive (CL) will report quarterly earnings of $0.86 per share, unchanged year over year, with revenues expected to decline by 3.8% to $4.87 billion [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.2% lower over the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock performance [3]. Revenue Projections - Analysts estimate 'Net Sales- Pet Nutrition' to reach $1.09 billion, reflecting a decrease of 0.8% year over year [5]. - 'Net Sales- Total Oral, Personal and Home Care' is projected at $3.77 billion, indicating a decline of 4.9% from the previous year [5]. - 'Net Sales- Oral, Personal and Home Care- North America' is expected to be $1.00 billion, showing a slight increase of 0.4% year over year [5]. - 'Net Sales- Oral, Personal and Home Care- Latin America' is estimated at $1.09 billion, suggesting a significant decline of 12.6% year over year [6]. - 'Net Sales- Oral, Personal and Home Care- Africa/Eurasia' is projected to be $273.66 million, down by 0.9% year over year [6]. - 'Net Sales- Oral, Personal and Home Care- Europe' is expected to reach $674.15 million, indicating a decrease of 5.2% from the prior year [7]. - 'Net Sales- Oral, Personal and Home Care- Asia Pacific' is projected at $727.36 million, reflecting a slight increase of 0.1% year over year [7]. Operating Profit Estimates - 'Operating profit- Total Oral, Personal and Home Care' is expected to be $1.01 billion, down from $1.04 billion year over year [8]. - 'Operating profit- Pet Nutrition' is projected at $239.30 million, an increase from $199 million in the previous year [8]. - 'Operating profit- Oral, Personal and Home Care- North America' is estimated at $209.78 million, down from $222 million year over year [9]. - 'Operating profit- Oral, Personal and Home Care- Latin America' is expected to be $364.08 million, compared to $405 million last year [9]. - 'Operating profit- Oral, Personal and Home Care- Africa/Eurasia' is projected at $66.32 million, slightly up from $66 million in the same quarter last year [10]. Stock Performance - Colgate-Palmolive shares have increased by 4.2% over the past month, contrasting with the S&P 500 composite's decline of 8.9% [10].